Free prostate cancer screenings are being offered to men in the area as part of a health initiative. The Mohawk Valley Health ...
Extended pelvic lymph node dissection prolongs biochemical recurrence-free and metastasis-free survivals in localized prostate cancer.
Men with a shorter membranous urethra appear more likely to experience urinary incontinence after laser enucleation for ...
ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that multiple abstracts ...
PYLARIFY TruVu™ (piflufolastat F 18) injection (also known as 18F-DCFPyL or PyL) is a fluorinated small molecule PSMA-targeted PET imaging agent that enables visualization of lymph nodes, bone and ...
Given the lack of effective treatment for chronic nonbacterial prostatitis (CNP) and the anti-inflammatory property of natural bioactive compound forsythiaside A (FTA), the therapeutic potential of ...
AB001 is a novel PSMA-targeted radioligand therapy designed to treat metastatic prostate cancer with potentially higher tumor dose rates and lower normal tissue toxicity. The phase 1 trial will enroll ...
OREM, UT, UNITED STATES, August 26, 2025 /EINPresswire.com/ -- Deep Bio, a global leader in AI-powered cancer diagnostics, today announced a strategic partnership ...
Prostate cancer (PC) is a major cause of cancer-related deaths worldwide, with far more diagnoses than deaths annually. Recent discussions have challenged whether Grade Group 1 (GG1) PC should be ...
Alonzo Mourning, a Basketball Hall of Famer, had surgery to remove his prostate after a Stage 3 prostate cancer diagnosis and is cancer-free following the March procedure, he told ESPN. Mourning spoke ...
Charles Peyton delivered a State-of-the-Art Lecture at the 2024 SES AUA meeting, focusing on managing complications following RPLND for testicular cancer. He presented a case study illustrating the ...
Secondary Analysis of the Rate of Second Primary Lung Cancer From Cancer and Leukemia Group B 140503 (Alliance) Trial of Lobar Versus Sublobar Resection for T1aN0 Non–Small-Cell Lung Cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results